Cefotiam hydrochloride CAS:74356-00-6
Cefotiam hydrochloride is prescribed by healthcare providers for the treatment of infections such as urinary tract infections, respiratory tract infections, skin and soft tissue infections, gynecological infections, and intra-abdominal infections. Before using cefotiam hydrochloride, patients should consult with a healthcare professional to determine the appropriate dosage and duration of treatment based on the specific type and severity of the infection. Patients receiving cefotiam hydrochloride should adhere to the prescribed dosing schedule and complete the full course of treatment as directed, even if symptoms improve before completion. This is essential to ensure the complete eradication of the bacterial infection and reduce the risk of developing antibiotic resistance. While cefotiam hydrochloride is generally well-tolerated, common side effects may include diarrhea, nausea, vomiting, or allergic reactions. Patients should be monitored for any adverse reactions during the course of treatment, and any severe or persistent side effects should be reported to a healthcare provider promptly for evaluation and management. Overall, cefotiam hydrochloride is an effective antibiotic when used appropriately under medical guidance for the treatment of bacterial infections.
Composition | C17H18N7NaO8S4 |
Assay | 99% |
Appearance | white powder |
CAS No. | 74356-00-6 |
Packing | Small and bulk |
Shelf Life | 2 years |
Storage | Store in cool and dry area |
Certification | ISO. |